Prev      Next

Practice Management Considerations for LipiView, DMI, and LipiFlow - TearScience

Last updated on July 15, 2015

© 2015 Corcoran Consulting Group. All rights reserved.

Question 4:

What are the indications for LipiView, DMI, and LipiFlow?

Answer:

Evaluation and management of evaporative dry eye disease exacerbated by meibomian gland dysfunction (MGD)[4] are the indications for LipiView, DMI, and LipiFlow.


[4] Nichols KK, Foulks GN, et al. The International Workshop on Meibomian Gland Dysfunction: Executive Summary. Invest Ophthalmol Vis Sci.  52(4):1922-1929. Link here. Accessed 06/24/15.

    

The reader is strongly encouraged to review federal and state laws, regulations, code sets (including ICD-10), and official instructions promulgated by Medicare and other payers. This document is not an official source nor is it a complete guide on reimbursement. The reader is reminded that this information, including references and hyperlinks, changes over time, and may be incorrect at any time following publication.

© 2015 Corcoran Consulting Group. All rights reserved. No part of this publication may be reproduced or distributed in any form or by any means, or stored in a retrieval system, without the written permission of the publisher. CPT is a registered trademark of the American Medical Association. Corcoran Consulting Group (800) 399-6565 | www.corcoranccg.com